centred chronic disease management and gender Susanna Palkonen EPF Board Member Health amp Gender though life Copenhagen 15 July Independent nongovernmental umbrella organisation set up in 2003 ID: 476456
Download Presentation The PPT/PDF document "Patient" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Patient –centred chronic disease management and gender
Susanna Palkonen,
EPF Board Member
Health & Gender though life, Copenhagen, 15 JulySlide2
Independent, non-governmental umbrella organisation set up in 2003VISION: High-quality, patient-centred, equitable healthcare for all patients in the EU MISSION:
To provide a strong and united patients’ voice –> Putting patients at the centre of EU health policy
EPF About us
54
member organisations –
150
million patients with chronic conditions across the EUSlide3
Significant differences in how men and women are affected by chronic diseases : prevalence, degree of severity, symptoms- biological differences & gender aspectsGender differences not only have a direct impact on the health behaviour, exposures, social factors, but also on needs and access to care of women and men. Men are more likely to die, at all age, of all the causes of death recorded by Eurostat;
Women
live longer, are more likely to suffer illness and disability in later lifeGovernments and health systems do not always recognize of address this sufficiently: health systems can also indirectly contributes to gender inequalities in health.
Gender and chronic diseasesSlide4
Research & Clinical trialsChronic disease managementInformal carers/familiesHealth literacy/ communication and information/ empowerment
Healthcare
professional training Role of patient organisations
Gender and chronic diseases
Gender dimension in:Slide5
Gender imbalance in health research both in content and process (source: ENGENDER Project, policy brief gender imbalance in health research)Content: slow recognition that health problems affect men and women differently, misdirected and incomplete approach to men and women’s need, and lack of recognition of interaction between gender and other social factor.
Process:
e.g. lack of disagregated data in project, gender imbalance in clinical trials, ethic committees, advisory bodies…
1. Research & Clinical trials Women and men are different in regards to their biological make-up (sex). Gender is not related to biology; it refers to cultural issues: men and women’s different roles and responsibilities in society, their access to and control over resources,
including information, and their
decision-making
power
.”
Value +
projectSlide6
Value + : explored gender and patient involvement in EC health related projectsRecommendations to better integrate gender perspective:Both men and women must be involved actively to generate a rich and relevant mix of approaches to health mattersMeaningful participation opportunities should take account of gender differences: e.g. men and women need to be approached differently
Male and female participation should be appropriate to the gender dimension of project objectives and outcomes
1. Research & Clinical trials
(2)
“Health research in all areas shows that gender factors have a great influence on causes, consequences and management of diseases and
ill-health.”
“Prevention
, treatment, rehabilitation and care delivery often need to be adapted to the gender of the people who will use them
”
Value + ToolkitSlide7
most research and clinical trials are done on men and extrapolated to womenresearch on the kinds of treatment that are best for women remains limited2006 EMA document “ICH - Gender considerations in clinical trials” showed that women involved but less so
in
phase Phase I and I-II studies. However, these are the studies in which safety, safe dosage range and side
effects are determined
1. Research & Clinical trials
(3)
EPF calls on the EU institutions to ensure that the revision of the clinical trial directive address this issue:
beyond the question of ethics- effectiveness and safety of medicines is at stakeSlide8
Men and Women have different health behaviours- they both have unmet needs, caused by different factorsGender may affect the provision of secondary prevention, treatment, management of a disease:Gender labelling negative consequences on diagnosis and treatment (e.g. CVD, osteoporosis)It may be affected by gender norms and stereotypes (e.g. mental health diagnosis and treatment)
The EC reported that most comprehensive screening programmes are targeting women’s health (in particular sexual and reproductive) and women’s specific cancer – BUT both for men and women still wide disparities in Member States in the availability of screening programmes
May affect other areas e.g. return to workHealth systems failures: due to lack of awareness/ recognition among patients, healthcare professionals, and decision makers
2. Chronic disease managementSlide9
most people providing informal care are women (2/3 according to WHO)Trend towards home care: potentially cost saving – key wish of patients to remain independent for as long as possible- better health outcomes.Need for adequate support and training of carersSome existing support services, but generally informal carers do not receive enough support and recognition
Known effect on employment- little research on quality of life and health of carers
Recognising informal carers: counted in statistics, accounted for in health economic representations, and taken into account when policy is made.
3
. Informal CareSlide10
Empowerment depends upon:High quality information to patients on treatment options,
their
disease and other health issues – one size does not fit allHealth
literacy: having the capacity to obtain, interpret and understand health information; to make sound health decisions; and to navigate the health servicesEnabling healthcare environment: organisation of health
system can be empowering or dis-empoweringWomen
and men have
different
needs
:
Women
act
as
pillar
in the
family
for health, for children, as informal carers, and for themselvesMen have lower understanding of health and prevention For both
groups- no
homogeneity
-
gender
may
be
combined
with other factors that affect their health literacy(education and culture, belonging to an ethnic minority…)
4. Health literacy& empowermentSlide11
Need to use the right channels to provide information to men and womenProvide patients with
information
they want and needKey role of patient organisations :They regularly liaise with grassroots patient communities that they know well, thus they can help ensure that health promotion and prevention messages are effectively communicated.
They can also reach out to populations with specific risk factors, or patients with particular disease, and from diverse ethnic and cultural patient groups.EPF calls for comprehensive strategy on information to patients at EU level that encompass health literacy
4. Health literacy& empowermentSlide12
Gender literacy of healthcare professional is a key issue, since they have an important role to play in empowering patients to participate in shared decision making, and contribute to building a patients’ own health literacy.The way gender is addressed in the content of medical and health care courses influences healthcare professionals’ training and therefore their future clinical practices.
HP
need to be aware of how gender influences health outcomes and health seeking behaviours.They also need to be trained in communicating more effectively with patients from both gender.
need for further availability of sex disaggregated dataContinuing Professional Development
5
. Health professionals’ trainingSlide13
Key role in providing user friendly information and putting in place health literacy initiativesPatients’ organisations can support health promotion efforts in the community through facilitating community outreach, community screening, and the development of community support
.
Given the differences in the health systems in EU Member States, patient organisations can play a highly effective role in identifying interventions that work for different patient groups in the different cultural and social contextsMeaningful patient involvement in clinical trials (health related research, in developing health related indicators, in health programmes and policy is essential to ensure that they reflect patients’ real needs
5. Role of patient organisationsSlide14
Gender is a universal factor and goes across other dimension (e.g. socio-economic, religious, cultural, ethnic, categories.) – need consider gender alongside other diversity issuesEPF has formulated recommendations on meaningful patient involvement as part of the Value + project which takes into account diversity issue- we call on Member States and EU institutions to implement them.
Women
and men should be encouraged to become equally involved in health matters that affect them
Final ThoughtsSlide15
THANK YOU FOR YOUR ATTENTION!More information:www.eu-patient.eu
info@eu-patient.eu